- Home
- PAC vs ALGN Comparison
PAC vs ALGN Comparison
Compare PAC & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAC
- ALGN
- Stock Information
- Founded
- PAC 1998
- ALGN 1997
- Country
- PAC Mexico
- ALGN United States
- Employees
- PAC N/A
- ALGN N/A
- Industry
- PAC Aerospace
- ALGN Industrial Specialties
- Sector
- PAC Consumer Discretionary
- ALGN Health Care
- Exchange
- PAC Nasdaq
- ALGN Nasdaq
- Market Cap
- PAC 11.7B
- ALGN 9.9B
- IPO Year
- PAC 2006
- ALGN N/A
- Fundamental
- Price
- PAC $215.80
- ALGN $134.51
- Analyst Decision
- PAC Hold
- ALGN Buy
- Analyst Count
- PAC 5
- ALGN 13
- Target Price
- PAC $210.00
- ALGN $190.50
- AVG Volume (30 Days)
- PAC 83.7K
- ALGN 1.3M
- Earning Date
- PAC 10-20-2025
- ALGN 10-29-2025
- Dividend Yield
- PAC 5.21%
- ALGN N/A
- EPS Growth
- PAC 13.32
- ALGN N/A
- EPS
- PAC 1.07
- ALGN 5.16
- Revenue
- PAC $1,870,491,921.00
- ALGN $3,982,622,000.00
- Revenue This Year
- PAC $58.23
- ALGN $2.48
- Revenue Next Year
- PAC $7.61
- ALGN $3.44
- P/E Ratio
- PAC $20.21
- ALGN $26.12
- Revenue Growth
- PAC 35.46
- ALGN 0.56
- 52 Week Low
- PAC $168.62
- ALGN $122.00
- 52 Week High
- PAC $259.33
- ALGN $246.19
- Technical
- Relative Strength Index (RSI)
- PAC 42.84
- ALGN 49.86
- Support Level
- PAC $206.91
- ALGN $131.90
- Resistance Level
- PAC $222.95
- ALGN $138.50
- Average True Range (ATR)
- PAC 5.67
- ALGN 4.57
- MACD
- PAC 1.09
- ALGN 0.10
- Stochastic Oscillator
- PAC 57.91
- ALGN 17.76
About PAC Grupo Aeroportuario Del Pacifico
Grupo Aeroportuario del Pacifico SAB de CV is engaged in the construction, development, and operation of airports in Mexico. The company's segment includes Guadalajara; Tijuana; Puerto Vallarta; San Jose del Cabo; Montego Bay; Hermosillo; Guanajuato and Other Airports. It generates maximum revenue from the Guadalajara segment.
About ALGN Align Technology Inc.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.